|
|
|
|
Head And Neck Cancers
Erbitux Approved to Treat Head and Neck Cancers Mar 9, 2006
HealthCentral.com The drug Erbitux has been approved to treat head and neck cancer, according to the US Food and Drug Administration. The drug, which ...
Erbitux Approved to Treat Head and Neck Cancers Mar 3, 2006
Forbes FRIDAY, March 3 (HealthDay News) -- The drug Erbitux (cetuximab) has been approved to treat cancers of the head and neck, the US Food and Drug Administration ...
Erbitux Now Approved for Head and Neck Cancers Mar 3, 2006
ACS News Center, The US Food and Drug Administration has approved the drug Erbitux (cetuximab) for certain patients with cancers of the head and neck. ...
Erbitux Approved for Head and Neck Cancers Mar 2, 2006
Cancerpage.com, Head and neck cancers can be particularly challenging to treat because they originate in organs important to every day functioning such as swallowing, speaking ...
FDA OKs Drug For Head, Neck Cancers Mar 2, 2006
CBS News ...use of standard chemotherapy. Head and neck cancers are more common in men and in people over age 50. Tobacco, including chewing ...
Physician Focus: Health care from the neck up: cancer check Mar 9, 2006
Tewksbury Advocate, According to the American Cancer Society, more than 70,000 Americans each year are diagnosed with head and neck cancers, and more than 15,000 die. ...
FDA gives greenlight for new treatment of head and neck cancer Mar 4, 2006
News-Medical.net, ...of head and neck cancer. Head and neck cancers are more common in men and in people over age 50. Tobacco and alcohol are factors ...
New Ideas Fuel Next Generation Gene Therapy Research Mar 7, 2006
eMaxHealth.com, There has been no way to prevent development of these head and neck cancers, and once they arise, they are diffuse and difficult to treat, says Clayman. ...
Chemotherapy plus Radiation Therapy Superior to Aggressive ... Mar 7, 2006
Cancer Consultants (press release), Treatment for unresectable head and neck cancers tends to be associated with significant side effects and a greatly reduced quality of life. ...
Erbitux given FDA greenlight for head, neck cancer Mar 2, 2006
Xinhua, ...according to the FDA. Head and neck cancers are more common in men and in people over age 50. Tobacco, including chewing tobacco ...
CORRECTED: FDA approves Erbitux for head and neck cancer Mar 2, 2006
Reuters.uk, ...in Europe under a licensing agreement with ImClone, said last week it expects European regulators to also approve the drug to treat head and neck cancers. ...
Biomarkers in Blood Detect Oral Cancer Mar 8, 2006
Cancer Consultants (press release), Research continues into early detection of head and neck cancers since a significant portion of patients has advanced disease upon diagnosis. ...
Sachs Associates 5th Annual North American Forum: Investing & ... Mar 9, 2006
TMCnet Advaxis has entered a Phase I/II clinical trial for its lead Listeria vaccine candidate, Lovaxin C, which targets cervical and head and neck cancers. ...
Advaxis Inc. Announces Approvals of Israeli and Mexican Regulators ... Mar 7, 2006
Genetic Engineering News, ...tumor responses. Advaxis' lead Listeria vaccine candidate, Lovaxin C, targets cervical and head and neck cancers. Further Listeria ...
Former Texas Gov. Ann Richards has esophagus cancer Mar 9, 2006
Food Consumer, 5, A medical history of other head and neck cancers increases the chance of developing a second cancer in the head and neck area, including esophageal cancer. ...
Erbitux Gets Added Approval Mar 1, 2006
TheStreet.com ...a new use for ImClone Systems' (IMCL:Nasdaq - commentary - research - Cramer's Take) Erbitux, endorsing the drug as a treatment for head and neck cancers. ...
Tetracaine mouthwash helps with pain linked to head and neck ... Feb 12, 2006
News-Medical.net, Oral pain is one of the most common side effects of radiation therapy for head and neck cancers, so this is great news for patients undergoing that treatment.".
ImClone Systems Issues Statement Regarding Positive Opinion from ... Feb 23, 2006
Genetic Engineering News, About 90 percent of head and neck cancers are of the squamous cell variety(3) and nearly all express epidermal growth factor receptor (EGFR), which is critical ...
Merck KGaA Receives EMEA Positive Opinion for Erbituxin Head and ... Feb 23, 2006
PharmaLive.com (press release), About 90 percent of head and neck cancers are of the squamous cell variety4 and nearly all express EGFR, which is critical for tumor growth.5 Although there ...
Addition of Erbitux® to Chemotherapy Promising as Initial ... Mar 7, 2006
Cancer Consultants (press release), ...treatment with irinotecan. Recently, Erbitux was also approved for treatment of advanced head and neck cancers. Researchers from ...
Merck KGaA Receives EMEA Positive Opinion for Erbitux in Head and ... Feb 23, 2006
DG News About 90% of head and neck cancers are of the squamous cell variety 4 and nearly all express EGFR, which is critical for tumor growth. ...
Old drugs find novel anti-cancer applications Feb 14, 2006
Xagena.it, Gossypol, once touted as a potential male contraceptive, may find a new use -- helping certain head and neck cancers overcome their resistance to Cisplatin. ...
CANCER PATIENTS INVEST IN TOMORROW Mar 4, 2006
South Wales Evening Post, ..."We are now gathering information from patients with breast, thyroid, colorectal, ovarian, prostate, renal and head and neck cancers," she said. ...
Compiled from wire reports Mar 2, 2006
Newsday, The Food and Drug Administration cleared Erbitux for head and neck cancers in combination with radiation treatment, the agency said yesterday. ...
Controversies: Is There a Role for Positron-Emission Tomographic ... Feb 16, 2006
Am J Neuroradiology (subscription) ...et al. Unknown primary detected by FDG-PET: a review of the present indications of FDG-PET in head and neck cancers. Acta Otorhinolaryngol ...
Advaxis Names VP of Finance Feb 28, 2006
Business New Jersey (subscription), University. North Brunswick-based Advaxis’ lead vaccine candidate, Lovaxin C, targets cervical, and head and neck cancers. The ...
Cancer Association plans March events Mar 2, 2006
Anderson Independent Mail (subscription), March 11 — New Voice Club will meet at 2 pm at CAA. This club is for survivors of laryngectomy and other head and neck cancers that affect speech. ...
ImClone: Erbitux Gets EU Panel Nod and Biogen to Spend Big On ... Feb 24, 2006
Financial News USA (press release), IMCL) and German drug maker Merck KGaA said Thursday a European panel as recommended that regulators approve Erbitux for the treatment of head and neck cancers ...
Addition of Erbitux® to Radiation Therapy Improves Survival in ... Feb 22, 2006
Cancer Consultants (press release), Previous studies have shown activity for Iressa®, another inhibitor of the EGFR pathway, for the treatment of head and neck cancers. ...
TREATMENT AT LAST FOR BRAIN TUMOUR PATIENT Mar 4, 2006
South Wales Evening Post, The Royal College of Radiologists has warned that patients with head and neck cancers waiting more than six weeks for post-operative radiotherapy were three ...
ImClone: Erbitux Gets EU Panel Nod Feb 23, 2006
Houston Chronicle, ...and German drug maker Merck KGaA said Thursday a European panel as recommended that regulators approve Erbitux for the treatment of head and neck cancers. ...
Energy-Boosting Supplements: Myths And Facts Feb 22, 2006
abc7news.com, ...caffeine. Warning: Research has found chronic consumption of this tea over years may increase the risk of head and neck cancers. ...
Incyte Announces 2005 Financial Results and Provides 2006 Guidance ... Feb 16, 2006
Business Wire (press release), ...is currently recruiting patients with a variety of solid tumors such as breast, non-small cell lung, prostate, colorectal and head and neck cancers, all of ...
Food for thought on cancer prevention Feb 20, 2006
Centre Daily Times, We know that tobacco causes 80 percent of lung cancers and head and neck cancers. We know that severe sunburns in early life increase the risk of skin cancer. ...
53pc Kept Waiting Too Long for Radiotherapy Feb 23, 2006
International News Service, Dr Williams said patients with head and neck cancers waiting more than six weeks for postoperative radiotherapy are three times more likely to suffer a return ...
Why a global pandemic just will not happen Feb 21, 2006
New Straits Times, ...to have their origins in infections and also the dates when the medical fraternity will come to accept such facts: head and neck cancers (2010), childhood ...
Scheduled Combination of Allos Therapeutics' Pralatrexate Plus ... Feb 14, 2006
PR Newswire (press release), ...one of the most widely applied antifolate chemotherapeutics and has been used to treat leukemia, breast, bladder, gastric, esophageal, head and neck cancers. ...
Booze Is Blighting Our Nation, Says George Best's Surgeon Feb 15, 2006
Medical News Today (press release), ...includes loss of brain function, painful inflammation of the pancreas - one of the worst pains that people can experience - and head and neck cancers, on top ...
TREATMENT DELAY FEARS OVER CANCER MAN'S FIGHT Feb 25, 2006
South Wales Evening Post, Royal College registrar of the faculty of oncology, Michael Williams, warned patients with head and neck cancers, waiting more than six weeks for post ...
Align Pharmaceuticals Makes Its Debut With Three New Products for ... 25 Jan 2006
Yahoo! News (press release) Both products will benefit people with xerostomia as a result of radiation treatment for head and neck cancers, or Sjogren's syndrome. ...
Erimos Pharmaceuticals Announces Phase I Study of EM-1421 ... Jan 24, 2006
Genetic Engineering News, Two early phase clinical studies of EM-1421 in the treatment of head and neck cancers, using direct injection into the tumor, yielded promising results, Frazer ...
Quality of life after treatment for head and neck cancer ... Jan 16, 2006
News-Medical.net, City Hospital, New Zealand, assessed whether pretreatment and post-treatment QOL is associated with long-term survival in patients with head and neck cancers. ...
Additional Evidence of Increased Cancer Risk in Survivors of ... Jan 20, 2006
Cancer Consultants (press release), ...with an increased risk of all cancers expect cancers of the reproductive system, and was most strongly linked with the development of head and neck cancers. ...
AstraZeneca and MD Anderson Cancer Center Form Umbrella Scientific ... Jan 18, 2006
Pharmaceutical Processing, ...clinical and clinical research on new treatments for cancer, focusing initially on aerodigestive diseases (eg, lung cancer, head and neck cancers or colorectal ...
15 Million Americans Suffer From Swallowing Disorders Jan 18, 2006
Emediawire (press release), ...point. Patients with traumatic brain injury and many who undergo radiation as a result of head and neck cancers also can be at risk. ...
(PRN) AstraZeneca and MD Anderson Cancer Center Form Umbrella ... Jan 12, 2006
Houston Chronicle, ...and clinical research on new treatments for cancer, focusing initially on aerodigestive diseases (eg, lung cancer, head and neck cancers or colorectal cancers ...
Stressgen receives final proceeds from sale of bioreagent business Jan 17, 2006
CNW Telbec (Communiqués de presse), Precancerous HPV-related conditions can progress into life-threatening diseases, including cervical, anal, and head and neck cancers. ...
Most cancer patients don't quit their jobs, but balancing work and ... Jan 15, 2006
North County Times, The highest rates of quitting were among those with blood, central nervous system and head and neck cancers, which tend to be the most debilitating and ...
Cancer Centers of North Carolina adds Eisenbeis and Sidhu to its ... Jan 16, 2006
Carolina Newswire (press release), Philadelphia, Pa. She has a strong interest in the treatment of head and neck cancers, as well as cancer in women. She continues ...
Cancer survival rates hit by long waiting lists Jan 13, 2006
Daily Mail - UK, Research into head and neck cancers found that patients waiting more than six weeks for post-operative radiotherapy were three times more likely to have the ...
Radiotherapy logjams 'are shortening patients' lives' Jan 12, 2006
Telegraph.co.uk, The specialists say that one review of 12 studies into the impact of delay for head and neck cancers found a threefold increase in local recurrence if ...
Scanning the scans Jan 8, 2006
ITP.net, ...surgically). PET scanning can also help in other malignancies, including head and neck cancers, gastrointestinal cancers, and lymphomas. ...
Pharma firm working with university Jan 12, 2006
Philadelphia Business Journal, A series of renewable, three-year agreements will initially focus on aerodigestive diseases such as lung cancer, head and neck cancers and colorectal cancers. ...
Most cancer patients don't quit their jobs, but balancing work and ... Jan 4, 2006
WXXA, ...whose health insurance is through their husband's employer are more likely to takeose with blood, central nervous system and head and neck cancers, which tend ...
CANCER patients are dying because of delays in getting ... Jan 12, 2006
Mirror.co.uk, They said research shows patients with head and neck cancers who waited over six weeks for post-op radiotherapy were three times more likely to have the ...
SCIENCES LECTURE LOOKS AT 'MAKING GENE THERAPY WORK' OCT. 25 Jan 6, 2006
Purchase College, ...into patients in clinical trials to treat lung cancer and will be used in upcoming trials to treat breast, pancreatic, head and neck cancers; Hepatitis B and C ...
BioCryst Says FDA OKs Human Test of Influenza Drug and Bristol ... Dec 23, 2005
Financial News USA (press release), ERBITUX's role in neutralizing the EGF receptor, an important mediator of a tumor's survival and a receptor overexpressed in virtually all head and neck cancers ...
Sabinsa's Curcumin C3 Complex Ingredient Preferred by MD Anderson ... Dec 19, 2005
NPIcenter (press release), ...of curcuminoids in conditions including lung, breast, multiple myeloma, pancreatic, myelodysplatic syndrome, colon, prostate and head and neck cancers. ...
2ND UPDATE: Amgen To Buy Abgenix For $2.2 Bln Dec 14, 2005
Business Online, ...first quarter of 2006. They added they also plan testing the therapy for the treatment of head and neck cancers. That news could ...
Swallowing After Cancer Dec 13, 2005
WFtv.com, HEAD AND NECK CANCERS: The American Cancer Society predicts nearly 30,000 new cases of cancer in the oral cavity and pharynx will be diagnosed in 2005. ...
Surviving breast cancer: does a woman's marital status matter ? Dec 15, 2005
Xagena.it, ..." In the past, we've looked at survival rates for men and women with head and neck cancers who undergo radiotherapy," explained Shelly B. Hayes, at Fox Chase. ...
Amgen to buy Abgenix Dec 15, 2005
MarketWatch ...panitumumab during the first quarter of 2006. They added they also plan testing the therapy for the treatment of head and neck cancers.
Recycled Or Revamped Therapeutics Find Novel Anti-cancer ... Nov 20, 2005
Science Daily (press release) Gossypol, once touted as a potential male contraceptive, may find a new use -- helping certain head and neck cancers overcome their resistance to cisplatin. ...
Stressgen announces closing of overallotment option Dec 13, 2005
CNW Telbec (Communiqués de presse), Precancerous HPV-related conditions can progress into life-threatening diseases, including cervical, anal, and head and neck cancers. ...
Amgen buying Abgenix for $2.2B Dec 14, 2005
Bizjournals.com, Fremont will produce Panitumumab. Panitumumab is being developed for metastic colorectal and head and neck cancers. Amgen says it ...
Latest Data on Marked Survival Improvement with Erbitux® in Head ... Nov 22, 2005
Cancer Consultants (press release), A large phase III clinical trial (the MCL-9815 trial) was recently conducted to evaluate the effectiveness of Erbitux in head and neck cancers. ...
Amgen seals deal to buy Abgenix for $2.2 billion Dec 15, 2005
9NEWS.com, The purchase gives Amgen full ownership of panitumumab, a drug for colon, head and neck cancers the companies have been developing jointly since 2002 under an ...
Addition of Taxol® to Chemotherapy Combination Improves Survival ... Nov 29, 2005
Cancer Consultants (press release), Additional trials are also needed to compare the effectiveness of chemotherapy to targeted therapies in the treatment of head and neck cancers. ...
Two Leading Biotech Publications Report on Advaxis' Potential ... Dec 12, 2005
PharmaLive.com (press release), ...tumor responses. Advaxis' lead Listeria vaccine candidate, Lovaxin C, targets cervical and head and neck cancers. Further Listeria ...
PDX Shows Promising Activity in Patients With Resistant T-Cell ... Dec 12, 2005
PR Newswire (press release), ...one of the most widely applied antifolate chemotherapeutics and has been used to treat leukemia, breast, bladder, gastric, esophageal, head and neck cancers. ...
OTN Appoints Kimberly A. Bergstrom, Pharm.D., as Chief Clinical ... Dec 9, 2005
Yahoo! News (press release) ...outcomes studies for community- based oncology practitioners, including those for breast, lung, colon, rectal, ovarian, head and neck cancers and supportive ...
Ethyol® Decreases Xerostomia Without Increasing Recurrences ... Nov 28, 2005
Cancer Consultants (press release), Oncology, Biology and Physics. Radiation therapy is commonly used to treat patients with head and neck cancers. Mucositis and xerostomia ...
Novel procedure adds heat to fight vs. some cancers Nov 24, 2005
AZ Central.com, Here's the quandary: Some studies have found hyperthermia could help certain patients with breast, cervical, head and neck cancers or melanoma. ...
Cancer Group Lists Top Treatment Advances for 2005 Dec 2, 2005
Forbes ...syndromes (MDS); the use of temozolomide in boosting brain tumor survival; and the success of the drug Erbitux against head and neck cancers, the researchers ...
Local cancer center teams with CU Dec 9, 2005
Vail Daily News, ...centers, Samdahl said Shaw deals primarily with breast and prostate cancer, although she noted the facility sees a fair share of head and neck cancers as well. ...
American Pharmaceutical Partners to Merge with Parent Company ... Nov 28, 2005
PR Newswire (press release), ...marketed in the US for metastatic breast cancer and being developed for adjuvant breast, lung, ovarian, prostate, melanoma and head and neck cancers in more ...
Researchers offer hope as UAE faces high cancer rates Dec 3, 2005
WAM - Emirates News Agency, ...bank for cancer research, a move researchers hope will help them determine why UAE residents have such unusually high numbers of thyroid, head and neck cancers ...
Breast cancer drug can treat weight loss Nov 22, 2005
United Press International A Wake Forest University study says a drug to treat breast cancer can also treat weight loss of patients receiving radiation for lung, head and neck cancers. ...
Cancer Wasting, Muscular Dystrophy Show Common Change Nov 28, 2005
Science Daily (press release) ...from muscle. Cancer wasting occurs most often in esophageal, stomach, colorectal, pancreatic, lung, and head and neck cancers. The ...
Midday Business Report: Shoppers can’t boost retail stocks Nov 28, 2005
Kansas City Star, ...in the United States for metastatic breast cancer and is being developed for other breast, lung, ovarian, prostate, melanoma and head and neck cancers in more ...
Cancer patients won't butt out Dec 2, 2005
Globe and Mail, ...in Houston. Roughly a third of cancers (including lung, head and neck cancers) are directly linked to tobacco use. Growing evidence ...
ABI In $4B Merger With APP To Create Abraxis BioScience Nov 28, 2005
BioWorld Online (subscription), In addition to breast cancer, Abraxane is in development for adjuvant breast, lung, ovarian, prostate, melanoma and head and neck cancers. ...
Daily Briefing Nov 29, 2005
Atlanta Journal Constitution (subscription), ...in the United States for metastatic breast cancer and is being developed for other breast, lung, ovarian, prostate, melanoma, and head and neck cancers in more ...
Joyce backs mouth cancer campaign Nov 18, 2005
Pendle Today, The Lead Clinician for East Lancashire's Head and Neck team, Steve Langton, said: "Head and neck cancers are extremely complex to deal with and we are ...
American Pharmaceutical buying American BioScience Nov 28, 2005
Bizjournals.com, ...cancer treatment marketed in the United States for metastatic breast cancer, and being developed for lung, ovarian, prostate, melanoma and head and neck cancers ...
American Pharmaceutical to merge with parent company Nov 28, 2005
Pharmaceutical Business Review ...which is approved in the US for metastatic breast cancer and is being developed for adjuvant breast, lung, ovarian, prostate, melanoma and head and neck cancers ...
Scientists direct embryonic stem cells to become cartilage cells Nov 20, 2005
News-Medical.net, When removing head and neck cancers, surgeons often have to cut away parts of cartilage, and then take grafts from other parts of the body. ...
Muscle wasting similar in cancer and MD Nov 18, 2005
NewKerala.com, ...dystrophy. Cancer wasting occurs most often in esophageal, stomach, colorectal, pancreatic, lung, and head and neck cancers. Cancer ...
Merck KGaA 3rd-Qtr Net Rises 57% on Takeda Payment (Update2) Oct 24, 2005
Bloomberg It's seeking regulatory approval of the drug as a treatment for head and neck cancers in a bid to widen the use and sales potential of the drug it developed ...
Lannett Gets FDA OK for Generic Salagen Oct 17, 2005
Forbes ...pilocarpine hydrochloride, the active ingredient in Salagen, a medication used to treat dry mouth resulting from radiation treatment of head and neck cancers. ...
Radiosensitizer May Benefit Head and Neck Cancer Patients Sep 6, 2005
...low oxygen levels. Unfortunately, many cancers, including head and neck cancers, tend to be hypoxic (lacking in oxygen). In order ... Cancer Consultants (press release),
Rehnquist's death unusual for thyroid cancer patients Sep 7, 2005
Michael Gornet, a medical oncologist specializing in head and neck cancers at Mayo Clinic in Scottsdale and Phoenix, says the most common types of thyroid ... Arizona Republic,
Predicting Response of Head and Neck Cancer to Accelerated ... Aug 30, 2005
According to a study published in the Journal of Clinical Oncology, patients with head and neck cancers are more likely to benefit from accelerated radiation ... Cancer Consultants (press release),
Inovio to Highlight the Treatment of Melanoma Using its Selective ... Sep 6, 2005
CE Mark and Inovio is conducting multi-center, pre-marketing observational studies treating newly diagnosed and recurrent head and neck cancers as well as skin ... Genetic Engineering News,
Merck KGaA Submits Erbitux Head, Neck Cancer Data for Approval Aug 30, 2005
US rights to ImClone Systems Inc.'s Erbitux cancer treatment, submitted to regulators new data on the drug's ability to treat head-and-neck cancers, aimed at ... Bloomberg
Advaxis' Listeria Cancer Vaccine Shows Strong Safety Profile In ... Aug 29, 2005
...it has successfully completed its pre-clinical toxicology studies of Lovaxin C, its Listeria Cancer Vaccine, for treatment of cervical and head and neck cancers ... Business Wire (press release),
'I'm kind of like Job' Aug 20, 2005
According to the American Cancer Society, cases of Nasopharyngeal make up about 0.25 percent of all cancers or 2 percent of all head and neck cancers in North ... Norman Transcript,
Science of tiny generates big developments Aug 17, 2005
..."It works for head and neck cancers, for pancreatic and prostate cancer, wherever it hides in the body," Pirollo said of tests in mice. ... Baltimore Sun,
Poison that is healthy in small quantities but deadly in excess Aug 15, 2005
...drinkers. In fact between a quarter and a half of all head and neck cancers are due to excessive drinking, according to Alcohol Concern. ... Independent,
Cancer Diagnostic Center is now open Aug 18, 2005
PET also shows the extent of the disease of lung, colorectal, breast, head and neck cancers, melanoma, lymphoma and other cancers, according to the release. ... Baxter Bulletin,
Radiation scare puts patients off -- Sep 15, 2005
Radiotherapy for head and neck cancers can result in problems with swallowing and speaking, and treatment for brain tumours may lead to dementia. ... / Telegraph.co.uk,
Imclone's Erbitux Approved in Canada for Colon Cancer (Update2) -- Sep 15, 2005
...said. ImClone last month asked the US Food and Drug Administration to allow expanded use of the drug for head and neck cancers. ... / Bloomberg
Radiosensitizer May Benefit Head and Neck Cancer Patients -- Sep 6, 2005
...low oxygen levels. Unfortunately, many cancers, including head and neck cancers, tend to be hypoxic (lacking in oxygen). In order ... / Cancer Consultants (press release),
Melanoma Treatment Using Selective Electrochemical Tumor Ablation ... -- Sep 11, 2005
CE Mark and Inovio is conducting multi-center, pre-marketing observational studies treating newly diagnosed and recurrent head and neck cancers as well as skin ... / Medical News Today (press release),
Predicting Response of Head and Neck Cancer to Accelerated ... -- Aug 30, 2005
According to a study published in the Journal of Clinical Oncology, patients with head and neck cancers are more likely to benefit from accelerated radiation ... / Cancer Consultants (press release),
Healthbeat: Facial Reconstruction -- Sep 12, 2005
...cancer. Unlike other head and neck cancers, tobacco smoking doesn’t appear to be linked to an increased risk for sinus/nasal tumors. ... / WHOI,
Merck KGaA Submits Erbitux Head, Neck Cancer Data for Approval -- Aug 30, 2005
US rights to ImClone Systems Inc.'s Erbitux cancer treatment, submitted to regulators new data on the drug's ability to treat head-and-neck cancers, aimed at ... / Bloomberg
Rehnquist's death unusual for thyroid cancer patients -- Sep 7, 2005
Michael Gornet, a medical oncologist specializing in head and neck cancers at Mayo Clinic in Scottsdale and Phoenix, says the most common types of thyroid ... / Arizona Republic,
Advaxis' Listeria Cancer Vaccine Shows Strong Safety Profile In ... -- Aug 29, 2005
...it has successfully completed its pre-clinical toxicology studies of Lovaxin C, its Listeria Cancer Vaccine, for treatment of cervical and head and neck cancers ... / Business Wire (press release),
'I'm kind of like Job' -- Aug 20, 2005
According to the American Cancer Society, cases of Nasopharyngeal make up about 0.25 percent of all cancers or 2 percent of all head and neck cancers in North ... / Norman Transcript,
Science of tiny generates big developments -- Aug 17, 2005
..."It works for head and neck cancers, for pancreatic and prostate cancer, wherever it hides in the body," Pirollo said of tests in mice. ... / Baltimore Sun,
Poison that is healthy in small quantities but deadly in excess -- Aug 15, 2005
...drinkers. In fact between a quarter and a half of all head and neck cancers are due to excessive drinking, according to Alcohol Concern. ... / Independent,
Cancer Diagnostic Center is now open -- Aug 18, 2005
PET also shows the extent of the disease of lung, colorectal, breast, head and neck cancers, melanoma, lymphoma and other cancers, according to the release. ... / Baxter Bulletin,
Radiosensitizer May Benefit Head and Neck Cancer Patients Sep 6, 2005
...low oxygen levels. Unfortunately, many cancers, including head and neck cancers, tend to be hypoxic (lacking in oxygen). In order ... Cancer Consultants (press release),
Rehnquist's death unusual for thyroid cancer patients Sep 7, 2005
Michael Gornet, a medical oncologist specializing in head and neck cancers at Mayo Clinic in Scottsdale and Phoenix, says the most common types of thyroid ... Arizona Republic,
Predicting Response of Head and Neck Cancer to Accelerated ... Aug 30, 2005
According to a study published in the Journal of Clinical Oncology, patients with head and neck cancers are more likely to benefit from accelerated radiation ... Cancer Consultants (press release),
Inovio to Highlight the Treatment of Melanoma Using its Selective ... Sep 6, 2005
CE Mark and Inovio is conducting multi-center, pre-marketing observational studies treating newly diagnosed and recurrent head and neck cancers as well as skin ... Genetic Engineering News,
Merck KGaA Submits Erbitux Head, Neck Cancer Data for Approval Aug 30, 2005
US rights to ImClone Systems Inc.'s Erbitux cancer treatment, submitted to regulators new data on the drug's ability to treat head-and-neck cancers, aimed at ... Bloomberg
Advaxis' Listeria Cancer Vaccine Shows Strong Safety Profile In ... Aug 29, 2005
...it has successfully completed its pre-clinical toxicology studies of Lovaxin C, its Listeria Cancer Vaccine, for treatment of cervical and head and neck cancers ... Business Wire (press release),
'I'm kind of like Job' Aug 20, 2005
According to the American Cancer Society, cases of Nasopharyngeal make up about 0.25 percent of all cancers or 2 percent of all head and neck cancers in North ... Norman Transcript,
Science of tiny generates big developments Aug 17, 2005
..."It works for head and neck cancers, for pancreatic and prostate cancer, wherever it hides in the body," Pirollo said of tests in mice. ... Baltimore Sun,
Poison that is healthy in small quantities but deadly in excess Aug 15, 2005
...drinkers. In fact between a quarter and a half of all head and neck cancers are due to excessive drinking, according to Alcohol Concern. ... Independent,
Cancer Diagnostic Center is now open Aug 18, 2005
PET also shows the extent of the disease of lung, colorectal, breast, head and neck cancers, melanoma, lymphoma and other cancers, according to the release. ... Baxter Bulletin,
Stocks Recover After London Explosions -- Jul 7, 2005
Drug Administration approval for its newest imaging device used to position and monitor patients during radiation treatment therapy for head and neck cancers. ... / Los Angeles Business Journal,
Erbitux Proves Effective With Head and Neck Cancers -- Jun 8, 2005
CHICAGO JUN 08, 2005 (Reuters) - An independent panel verified that a clinical trial showed ImClone Systems Inc.'s drug Erbitux used in combination with ... / Cancerpage.com,
North American Scientific Receives FDA 510(K) Clearance to Market ... -- Jul 7, 2005
...to market nTRAK, its new stereotactic image guidance system used to position and monitor patients during radiation therapy treatments for head and neck cancers ... / RedNova.com,
Clinigene to be third party CRO -- Jul 6, 2005
...trials for recombinant human insulin for Biocon, Clinigene is presently conducting IIB trials for novel anti-EGFr monoclonal antibody for head and neck cancers ... / Business Standard,
Imclone hops on head and neck cancer news -- Jun 8, 2005
...rose more than 10% on Wednesday after the company reported its drug Erbitux had been shown to be effective in treating head and neck cancers. ... / Investor's Business Daily (subscription)
Q & A: What to Know About Facial Prosthetics -- Jul 1, 2005
MD Anderson surgeons fabricate one to two facial prostheses each week for patients with head and neck cancers. Two types of specialists ... / CancerWise
ImClone shares rise on head and neck cancer news -- Jun 8, 2005
...and Drug Administration about what additional steps need to be taken by the company in order to apply to have Erbitux approved to treat head and neck cancers. ... / Investor's Business Daily (subscription)
Councillors unite against health plans -- Jun 26, 2005
Patients in Suffolk who are suffering from head and neck cancers could face long journeys for life-saving surgery if the controversial ideas get the go ahead. ... / East Anglian Daily Times,
... Go to the Article -- Jul 1, 2005
...of a tumor, just as cardiac disease doesn’t start with a heart attack, Hong began investigating whether vitamin A could prevent head and neck cancers. ... / CancerWise
Anger at cancer unit move proposal -- Jun 10, 2005
By Rebecca Sheppard. PATIENTS in Suffolk who are suffering from head and neck cancers could face long journeys for life-saving surgery. ... / East Anglian Daily Times,
Erbitux: ImClone Makes Headway -- Jun 8, 2005
The biotech's stock rose on independent affirmation of its drug's action against head and neck cancers. Next: Seeking FDA approval for this use. ... / BusinessWeek
ImClone Shares Jump on Erbitux Data, Icahn Plan to Buy Shares -- Jun 8, 2005
...jumped as much as 18 percent after an independent review confirmed that the drug Erbitux is effective for head and neck cancers and billionaire investor Carl ... / Bloomberg
Warren General Hospital Introduces Promising Cesium-131 Isotope ... -- Jun 28, 2005
...for prostate cancer patients, although the treatment holds promise for other types of cancer, including breast, brain, liver, head and neck cancers, and other ... / Business Wire (press release),
Community welcomes oncology center -- Jun 29, 2005
...million facility on Van Rensselaer Street, adjacent to the hospital's main building, will allow patients with breast, lung, rectal, head and neck cancers to be ... / The Saratogian,
Can ImClone Rise Again? -- Jun 8, 2005
...that may make it hard for doctors, patients and insurers to decide how to use the drug: In many cancer centers, patients whose head and neck cancers are of the ... / Forbes
Imclone hops on drug news -- Jun 8, 2005
...advanced notably in pre-market trade on news that its drug Erbitux had been shown to be effective in treating head and neck cancers. ... / MarketWatch
Doctors Tackling Cancer in Las Tunas, Cuba -- Jun 21, 2005
Scientists have proved that there is a direct relationship between malnutrition, toxic habits like drinking and smoking, and head and neck cancers, for example ... / Periódico 26,
ImClone shares gain on positive review data for Erbitux - update 3 -- Jun 9, 2005
...with the FDA regarding additional measures to be taken before applying for the approval of Erbitux in the treatment of head and neck cancers, the company said ... / New Ratings
PET scans valuable, group says -- Jun 21, 2005
PET scans are used to help detect head and neck cancers, the vast majority of lung cancers, lymphoma, colorectal, melanoma and breast cancer as well as heart ... / Globe and Mail,
Stressgen Biotechnologies completes manufacture of HSPE7 for use ... -- Jun 21, 2005
Precancerous HPV-related conditions can progress into life-threatening diseases, including cervical, anal, and head and neck cancers. ... / Canada NewsWire (press release),
| |
